JP2003523735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003523735A5 JP2003523735A5 JP2001538509A JP2001538509A JP2003523735A5 JP 2003523735 A5 JP2003523735 A5 JP 2003523735A5 JP 2001538509 A JP2001538509 A JP 2001538509A JP 2001538509 A JP2001538509 A JP 2001538509A JP 2003523735 A5 JP2003523735 A5 JP 2003523735A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated
- seq
- antibody
- cells
- biological sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44051499A | 1999-11-15 | 1999-11-15 | |
| CA2,288,307 | 1999-11-15 | ||
| US09/440,514 | 1999-11-15 | ||
| CA2288307A CA2288307C (en) | 1999-11-15 | 1999-11-15 | Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same |
| PCT/EP2000/011697 WO2001036630A2 (en) | 1999-11-15 | 2000-11-15 | Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003523735A JP2003523735A (ja) | 2003-08-12 |
| JP2003523735A5 true JP2003523735A5 (https=) | 2008-01-17 |
| JP4776845B2 JP4776845B2 (ja) | 2011-09-21 |
Family
ID=25681295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001538509A Expired - Fee Related JP4776845B2 (ja) | 1999-11-15 | 2000-11-15 | ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1240326B1 (https=) |
| JP (1) | JP4776845B2 (https=) |
| AT (1) | ATE423848T1 (https=) |
| AU (1) | AU783899B2 (https=) |
| DE (1) | DE60041655D1 (https=) |
| DK (1) | DK1240326T3 (https=) |
| ES (1) | ES2321687T3 (https=) |
| WO (1) | WO2001036630A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10261223A1 (de) * | 2002-12-20 | 2004-07-08 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Steigerung der Immunantwort durch Substanzen, welche die Funktion von Natürlichen Killerzellen beeinflussen |
| WO2004056392A1 (en) * | 2002-12-23 | 2004-07-08 | Innate Pharma | Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same |
| EP1445614A1 (en) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
| US7803376B2 (en) | 2003-07-24 | 2010-09-28 | Innate Pharma S.A. | Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
| WO2005105848A1 (en) * | 2004-04-30 | 2005-11-10 | Innate Pharma | Compositions and methods for enhancing nk cell activity |
| WO2006009731A1 (en) * | 2004-06-18 | 2006-01-26 | Genentech, Inc. | Methods of using apo2l receptor agonists and nk cell activators |
| ATE548389T1 (de) | 2004-08-03 | 2012-03-15 | Innate Pharma | Therapeutische und diagnostische verfahren und zusammensetzungen zum targeting von 4ig-b7-h3 und dem entsprechenden nk-zellen-rezeptor |
| EP1626059A1 (en) * | 2004-08-09 | 2006-02-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 |
| AU2005321017B2 (en) | 2004-12-28 | 2011-02-24 | Innate Pharma S.A. | Monoclonal antibodies against NKG2A |
| AU2006301163B2 (en) | 2005-10-14 | 2012-02-23 | Innate Pharma | Compositions and methods for treating proliferative disorders |
| KR101662622B1 (ko) * | 2007-10-04 | 2016-10-05 | 지모제넥틱스, 인코포레이티드 | Ｂ7 패밀리 구성원 ｚＢ7Ｈ6 및 관련된 조성물 및 방법 |
| AU2016299166B2 (en) * | 2015-07-24 | 2022-03-31 | Innate Pharma | Methods for detecting tissue infiltrating NK cells |
| AU2018371114A1 (en) | 2017-11-21 | 2020-05-07 | Innate Pharma | Multispecific antigen binding proteins |
| EP3737692A4 (en) | 2018-01-09 | 2021-09-29 | Elstar Therapeutics, Inc. | CALRETICULIN AND MODIFIED T-LYMPHOCYTES BINDING CONSTRUCTIONS FOR THE TREATMENT OF DISEASES |
| EP3818083A2 (en) | 2018-07-03 | 2021-05-12 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| JP7710373B2 (ja) | 2019-02-21 | 2025-07-18 | マレンゴ・セラピューティクス，インコーポレーテッド | Ｔ細胞関連のがん細胞に結合する多機能性分子およびその使用 |
| AU2020224681A1 (en) | 2019-02-21 | 2021-09-16 | Marengo Therapeutics, Inc. | Antibody molecules that bind to NKp30 and uses thereof |
| CN116234829A (zh) | 2020-01-03 | 2023-06-06 | 马伦戈治疗公司 | 抗tcr抗体分子及其用途 |
| EP4448095A1 (en) | 2021-12-14 | 2024-10-23 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Depletion of nk cells for the treatment of adverse post-ischemic cardiac remodeling |
| JP7821427B2 (ja) * | 2022-01-27 | 2026-02-27 | 学校法人 東洋大学 | ナチュラルキラー細胞活性の測定方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09502089A (ja) * | 1993-08-27 | 1997-03-04 | ダナ−ファーバー キャンサー インスティチュート インコーポレイテッド | ナチュラルキラー細胞特異性抗原およびこの抗原を識別する抗体 |
| ZA9810133B (en) * | 1997-11-07 | 1999-05-17 | Biogen Inc | BMOG a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for ummonomodulatory purposes |
| US7396681B1 (en) * | 1998-03-27 | 2008-07-08 | Gabriele Multhoff | Application of Hsp70 proteins |
-
2000
- 2000-11-15 AT AT00989877T patent/ATE423848T1/de active
- 2000-11-15 AU AU26677/01A patent/AU783899B2/en not_active Ceased
- 2000-11-15 ES ES00989877T patent/ES2321687T3/es not_active Expired - Lifetime
- 2000-11-15 DK DK00989877T patent/DK1240326T3/da active
- 2000-11-15 EP EP00989877A patent/EP1240326B1/en not_active Expired - Lifetime
- 2000-11-15 WO PCT/EP2000/011697 patent/WO2001036630A2/en not_active Ceased
- 2000-11-15 DE DE60041655T patent/DE60041655D1/de not_active Expired - Lifetime
- 2000-11-15 JP JP2001538509A patent/JP4776845B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003523735A5 (https=) | ||
| DE69325577T2 (de) | Mn-gen und protein | |
| JPH09505723A (ja) | ４３ｋｄヒトガン抗原からの免疫反応性ペプチド配列 | |
| JP2007532139A5 (https=) | ||
| EP1012292A1 (en) | Ntn-2 member of tnf ligand family | |
| EP0991759A1 (en) | Ntn-2 member of tnf ligand family | |
| JP4776845B2 (ja) | ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体 | |
| US6979546B2 (en) | Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same | |
| KR20080059449A (ko) | 치료용 약제 | |
| JP2025131589A (ja) | 固形腫瘍を治療するための遺伝子操作しているγδ－Ｔ細胞及び遺伝子操作していないγδ－Ｔ細胞に関する組成物及び方法 | |
| JP2003525566A (ja) | １２５個のヒト分泌タンパク質 | |
| US8071716B2 (en) | Thymus-specific protein | |
| TW202306971A (zh) | 用於治療視神經脊髓炎之肽及方法 | |
| US20070148686A1 (en) | Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof | |
| JP3231262B2 (ja) | ヒトＴｈ１特異的タンパク質及びこれをコードする遺伝子、並びにこれに関連する形質転換体、組換えベクター及び抗体 | |
| CA2104997A1 (en) | Bone-related cadherin-like protein and process for its production | |
| JP3924330B2 (ja) | 新規タンパク質、その遺伝子、アポトーシス誘導用試薬及び抗ガン剤 | |
| WO1998029448A1 (en) | Human pathogenesis-related protein | |
| JP2000515726A (ja) | 分泌蛋白をコードする成人ｐｂｍｃ由来のポリヌクレオチド | |
| JP2002504361A (ja) | ３６個のヒト分泌タンパク質 | |
| GB2375540A (en) | Vertebrate globin | |
| EP4512410A1 (en) | Novel-peptide-based anticancer immunotherapeutic agent | |
| KR102689877B1 (ko) | CD300c 항원 또는 그의 수용체에 특이적으로 결합하는 키메라 항원 수용체 | |
| JPH03502446A (ja) | 動物およびヒトのレクチン類の少なくとも一部分の配列を再現するアミノ酸配列，それを得る方法，およびその診断および治療への用途 | |
| WO1999039725A1 (en) | Desert hedgehog related nucleic acids and proteins |